Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | €33.60 | €41.51 | 23.549% |
| Arrowhead Pharmaceuticals Inc. | 16 | 2 | 4 | 0 | €22.69 | €54.74 | 141.230% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.36 | - | - |
| Xencor Inc. | 10 | 1 | 1 | 0 | €20.00 | €32.58 | 62.895% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 5 | 0 | €38.40 | €84.74 | 120.688% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.26 | €3.70 | 192.953% |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | €121.60 | €140.60 | 15.628% |
| United Therapeutics | 20 | 0 | 2 | 0 | €255.70 | €287.40 | 12.398% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.63 | €26.01 | 26.061% |
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | €138.10 | €236.30 | 71.106% |
| Halozyme Therapeutics Inc. | 16 | 0 | 3 | 0 | €47.02 | €47.17 | 0.319% |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | €9.65 | €17.64 | 82.774% |
| Icon plc | 22 | 0 | 4 | 0 | €297.40 | €324.79 | 9.209% |
| Horizon Pharma plc | 4 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 7 | 0 | 1 | 0 | €44.00 | €48.75 | 10.794% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.87 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €126.00 | €150.00 | 19.048% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €95.82 | - | - |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €371.10 | €419.64 | 13.079% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.80 | €65.00 | -4.130% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| QIAGEN NV | 8 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |